BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16526326)

  • 1. Pancytopenia after low dose methotrexate therapy in a hemodialysis patient: case report and review of literature.
    Yang CP; Kuo MC; Guh JY; Chen HC
    Ren Fail; 2006; 28(1):95-7. PubMed ID: 16526326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe pancytopenia associated with low-dose methotrexate therapy for rheumatoid arthritis.
    Calvo-Romero JM
    Ann Pharmacother; 2001 Dec; 35(12):1575-7. PubMed ID: 11793624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of pancytopenia secondary to low-dose pulse methotrexate therapy in a patient with rheumatoid arthritis and renal insufficiency.
    Park GT; Jeon DW; Roh KH; Mun HS; Lee CH; Park CH; Kang KW; Kim SM; Kang JM; Park HC
    Korean J Intern Med; 1999 Jan; 14(1):85-7. PubMed ID: 10063319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pancytopenia and Pneumocystis carinii pneumonia associated with low dose methotrexate pulse therapy for rheumatoid arthritis--case report and review of literature].
    Kitsuwa S; Matsunaga K; Kawai M; Tsuzi T; Kato K; Tani K; Okubo T
    Ryumachi; 1996 Jun; 36(3):551-8. PubMed ID: 8779792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Toxicity of low-dose methotrexate in rheumatoid arthritis--clinical characteristics in patients with MTX-induced pancytopenia and interstitial pneumonitis].
    Ohosone Y; Okano Y; Kameda H; Hama N; Matsumura M; Nojima T; Nakamura K; Kuwana M; Ogasawara T; Hirakata M; Yoshida T; Mimori T; Akizuki M; Ikeda Y
    Ryumachi; 1997 Feb; 37(1):16-23. PubMed ID: 9128419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancytopenia after Low-Dose Methotrexate Therapy in Two Hemodialysis Patients with Rheumatoid Arthritis.
    Pu T; Ni Y; Li PH; Yu D; Yu Q; Yu LM
    Am J Med Sci; 2022 Feb; 363(2):185-190. PubMed ID: 34562416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-onset pancytopenia and skin ulcer following low-dose methotrexate therapy.
    Hocaoglu N; Atilla R; Onen F; Tuncok Y
    Hum Exp Toxicol; 2008 Jul; 27(7):585-9. PubMed ID: 18829735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate-induced pancytopenia: a case series of 46 patients.
    Ajmani S; Preet Singh Y; Prasad S; Chowdhury A; Aggarwal A; Lawrence A; Misra R; Mishra R; Agarwal V
    Int J Rheum Dis; 2017 Jul; 20(7):846-851. PubMed ID: 28261918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis?
    Cansu DÜ; Teke HÜ; Bodakçi E; Korkmaz C
    Clin Rheumatol; 2018 Dec; 37(12):3419-3425. PubMed ID: 30056523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years.
    Lim AY; Gaffney K; Scott DG
    Rheumatology (Oxford); 2005 Aug; 44(8):1051-5. PubMed ID: 15901903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal pancytopenia in a hemodialysis patient after treatment with low-dose methotrexate.
    Cheung KK; Chow KM; Szeto CC; Tai MH; Kwan BC; Li PK
    J Clin Rheumatol; 2009 Jun; 15(4):177-80. PubMed ID: 19502905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cotton wool spots as an indicator of methotrexate-induced blood dyscrasia.
    Klemencic S
    Optometry; 2010 Apr; 81(4):177-80. PubMed ID: 20346888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Severe pancytopenia and stomatitis in a patient treated with low-dose methostraxate].
    Bruggisser M; Rätz Bravo AE; Krähenbühl S
    Praxis (Bern 1994); 2011 Jun; 100(13):765-74; quiz 772. PubMed ID: 21698560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous erosions: a herald for impending pancytopenia in methotrexate toxicity.
    Shiver MB; Hall LA; Conner KB; Brown GE; Cheung WL; Wirges ML
    Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose methotrexate-induced pancytopenia.
    Preet Singh Y; Aggarwal A; Misra R; Agarwal V
    Clin Rheumatol; 2007 Jan; 26(1):84-7. PubMed ID: 16636937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases.
    Mori S; Hidaka M; Kawakita T; Hidaka T; Tsuda H; Yoshitama T; Migita K; Ueki Y
    PLoS One; 2016; 11(4):e0154744. PubMed ID: 27128679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for malignant rheumatoid arthritis].
    Okuda Y; Oyama T; Oyama H; Miyamoto T; Takasugi K
    Ryumachi; 1995 Aug; 35(4):699-704. PubMed ID: 7482069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects of low dose methotrexate in rheumatoid arthritis patients.
    Gilani ST; Khan DA; Khan FA; Ahmed M
    J Coll Physicians Surg Pak; 2012 Feb; 22(2):101-4. PubMed ID: 22313647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancytopenia related eosinophilia in rheumatoid arthritis: a specific methotrexate phenomenon?
    Bruyn GA; Velthuysen E; Joosten P; Houtman PM
    J Rheumatol; 1995 Jul; 22(7):1373-6. PubMed ID: 7562775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis.
    Gutierrez-Ureña S; Molina JF; García CO; Cuéllar ML; Espinoza LR
    Arthritis Rheum; 1996 Feb; 39(2):272-6. PubMed ID: 8849378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.